The existing studies of the chemobrain phenomenon seem to be based primarily on breast-cancer patients, who often undergo hormone therapy in addition to chemo.A quick Pubmed search for Tim Ahles of Sloan-Kettering, one of the investigators referenced in the Times, led me to his recently published article in Nature Reviews Cancer.